Villacencio, Michael John V.

HRN: 22-29-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2022
CEFTRIAXONE 1G (VIAL)
12/09/2022
12/15/2022
IV
2g
OD
T/c Seizure Disorder, R/o Cns Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: